Castillon, Jorenda S.
HRN: 23-11-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/27/2023
06/02/2023
IV
750mg
OD
Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes